PharmaMar collaboration activities with the following patients associations
Search Location
Presencia Internacional: 0
Loading...
Directions
Get Your Directions
Show Distance In
Use my location to find the closest Service Provider near me
2018
More information about the collaborations
2017
More information about the collaborations
2016
More information about the collaborations
2015
More information about the collaborations
2014
More information about the collaborations
Oncology pipeline
PharmaMar develops and commercializes YONDELIS® in Europe and has three clinical-stage drug candidates under development for several types of solid and hematological cancers, Aplidin ®, Lurbinectedin, and PM184.
Shareholders and Investors
Financial Information of the Company, stock information, official notices to the CNMV (Spanish Securities & Exchange Commission), product portfolio and other information.
Newsroom
If you need information about the company, our clinical trials, corporate images or multimedia, visit our newsroom